| Radiation Therapy in Treating Women With Localized Breast Cancer (NCT00107497) | Institute of Cancer Research, United Kingdom | 2004-10-05 |
| Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant (NCT00293384) | Barbara Ann Karmanos Cancer Institute | 2004-10-01 |
| Bioequivalency Study of Exemestane 25 mg Tablet Under Fed Conditions (NCT01331434) | Roxane Laboratories | 2004-10-01 |
| A Study of Pemetrexed Plus Doxorubicin Given to Patients With Advanced Breast Cancer (NCT00102219) | Eli Lilly and Company | 2004-10-01 |
| Docetaxel, Cisplatin and Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer (NCT00155259) | National Taiwan University Hospital | 2004-10-01 |
| Spousal Relationships and Pain in Metastatic Breast Cancer (NCT00386620) | M.D. Anderson Cancer Center | 2004-10-01 |
| Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer (NCT00093795) | NSABP Foundation Inc | 2004-10-01 |
| Six vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer (NCT00615602) | Hellenic Oncology Research Group | 2004-10-01 |
| Phase II Trial of Preoperative Therapy With Gefitinib and Chemotherapy in Patients With ERneg Breast Cancer (NCT00239343) | AstraZeneca | 2004-10-01 |
| Dose-Dense Docetaxel Before or After Doxorubicin/Cyclophosphamide in Axillary Node-Positive Breast Cancer (NCT00201708) | Ohio State University Comprehensive Cancer Center | 2004-10-01 |
| Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer (NCT00148707) | Dana-Farber Cancer Institute | 2004-10-01 |
| Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer (NCT00096668) | Achieve Life Sciences | 2004-10-01 |
| RayGel-An Alternative for Skin Care During External Beam Radiation (NCT00266331) | Nathalie Johnson | 2004-10-01 |
| AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Aromatase Inhibitor Therapy for Non-metastatic Breast Cancer (NCT00089661) | Amgen | 2004-10-01 |
| Study of D-Methadone in Patients With Chronic Pain (NCT00588640) | Memorial Sloan Kettering Cancer Center | 2004-10-01 |
| A Study of Biweekly Pemetrexed and Gemcitabine in Patients With Metastatic Breast Cancer (NCT00191347) | Eli Lilly and Company | 2004-10-01 |
| Multi-catheter High Dose Rate (HDR) Breast Brachytherapy (NCT00214149) | University of Wisconsin, Madison | 2004-10-01 |
| Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies (NCT00451022) | National Cancer Institute (NCI) | 2004-09-13 |
| Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data (NCT00341939) | National Cancer Institute (NCI) | 2004-09-07 |
| Bone Response in Metastatic Breast Cancer Involving Bones (NCT00420433) | M.D. Anderson Cancer Center | 2004-09-01 |
| Denosumab (AMG 162) in Bisphosphonate Naive Metastatic Breast Cancer (NCT00091832) | Amgen | 2004-09-01 |
| Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer (NCT00087347) | Massachusetts General Hospital | 2004-09-01 |
| Taxotere and Adriamycin/Cytoxan (AC) Validation in Breast Cancer Patients (NCT00206518) | Mothaffar Rimawi | 2004-09-01 |
| Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery (NCT00562718) | University of Texas Southwestern Medical Center | 2004-09-01 |
| Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer (NCT01148875) | UNC Lineberger Comprehensive Cancer Center | 2004-09-01 |
| Assessment of Tartrate-Resistant Acid Phosphatase (TRAP) as a Bone Resorption Marker in Stage IV Breast Cancer Patients With Bone Metastasis (NCT00264082) | University of Louisville | 2004-09-01 |
| A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast Cancer (NCT00087620) | Hoffmann-La Roche | 2004-09-01 |
| A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer (NCT00091442) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-09-01 |
| Coenzyme Q10 in Relieving Treatment-Related Fatigue in Women With Breast Cancer (NCT00096356) | Wake Forest University Health Sciences | 2004-08-27 |
| Vaccine Treatment for Advanced Breast Cancer (NCT00090480) | NewLink Genetics Corporation | 2004-08-01 |
| Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients (NCT00516269) | M.D. Anderson Cancer Center | 2004-08-01 |
| Randomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer (NCT00431080) | Hellenic Oncology Research Group | 2004-08-01 |
| Capecitabine, Vinorelbine, and Trastuzumab in Treating Patients With Metastatic Breast Cancer (NCT00093808) | Alliance for Clinical Trials in Oncology | 2004-08-01 |
| Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery (NCT00305825) | University of California, San Francisco | 2004-08-01 |
| Reducing Arm Morbidity in Pre- and Post-breast Cancer Surgery (NCT00170235) | McGill University | 2004-08-01 |
| CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer (NCT00214162) | University of Wisconsin, Madison | 2004-08-01 |
| Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer (NCT00427245) | Anglo Celtic Cooperative Oncology Group | 2004-08-01 |
| Reduced Dexamethasone Pre-Medication Dose in Elderly Patients Receiving Weekly Docetaxel (NCT00215748) | Geriatric Oncology Consortium | 2004-08-01 |
| Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment (NCT00087958) | Sanofi | 2004-08-01 |
| Neoadjuvant GW572016 to Treat Breast Cancer (NCT00206427) | Baylor Breast Care Center | 2004-08-01 |
| PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer (NCT00088413) | National Cancer Institute (NCI) | 2004-07-21 |
| An Access Delivery Model That Eliminates Barriers to Breast Cancer Care Delivery (NCT00597454) | Memorial Sloan Kettering Cancer Center | 2004-07-01 |
| Arimidex Observational: Reason for and Effect of Change From Tamoxifen (NCT00246961) | AstraZeneca | 2004-07-01 |
| Radiation Dose Intensity Study in Breast Cancer in Young Women (NCT00212121) | The Netherlands Cancer Institute | 2004-07-01 |
| Preoperative Cisplatin in Early Stage Breast Cancer (NCT00148694) | Dana-Farber Cancer Institute | 2004-07-01 |
| Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer (NCT00090844) | University of South Florida | 2004-07-01 |
| A Trial of Gemcitabine Combined With Vinorelbine as First Line Chemotherapy for Metastatic Breast Cancer (NCT00192062) | Eli Lilly and Company | 2004-07-01 |
| The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity (NCT00530101) | University of Miami | 2004-07-01 |
| Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions (NCT01331421) | Roxane Laboratories | 2004-07-01 |
| Radiation Therapy in Treating Older Women Who Are Undergoing Surgery for Stage I or Stage II Breast Cancer (NCT00104702) | UNICANCER | 2004-07-01 |
| A Weight-Loss Program in Helping Obese Black Women Lose Weight (NCT00859989) | University of Illinois at Chicago | 2004-07-01 |
| A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) (NCT00196872) | GBG Forschungs GmbH | 2004-07-01 |
| Partial Breast Irradiation With Chemotherapy (NCT00278109) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2004-07-01 |
| Cytokine Regulation of Natural Killer Receptors in Inhibiting Activated T Cell Function (NCT00173290) | National Taiwan University Hospital | 2004-07-01 |
| A Multi Modality Surveillance Program for Women At High Risk for Breast Cancer (NCT00989638) | University of Chicago | 2004-06-23 |
| Hydralazine as Demethylating Agent in Breast Cancer (NCT00575978) | University of Arkansas | 2004-06-01 |
| Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer (NCT00146601) | Dana-Farber Cancer Institute | 2004-06-01 |
| Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases (NCT00587964) | Memorial Sloan Kettering Cancer Center | 2004-06-01 |
| S0338, Imatinib Mesylate and Capecitabine in Treating Women With Progressive Stage IV Breast Cancer (NCT00087152) | National Cancer Institute (NCI) | 2004-06-01 |
| Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Advanced Breast Cancer (NCT00093145) | Celgene | 2004-06-01 |
| Study in Elderly Patients With Early Breast Cancer (ICE) (NCT00196859) | GBG Forschungs GmbH | 2004-06-01 |
| Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors (NCT00086762) | M.D. Anderson Cancer Center | 2004-06-01 |
| Assessment of Endometrial Changes in Postmenopausal Women With Breast Cancer in Adjuvant Treatment With Anastrozole (NCT00623519) | AstraZeneca | 2004-06-01 |
| An Observational Study of Current Practice Pattern on the Treatment of Women With Metastatic Breast Cancer Whose Tumors Overexpress Her2neu (NCT00153218) | Cancer Research Network | 2004-06-01 |
| Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer (NCT00093002) | AstraZeneca | 2004-06-01 |
| Breast Cancer, Breast Disease, and Pesticides (NCT00341315) | National Cancer Institute (NCI) | 2004-05-17 |
| Lymphedema Prevention in Breast Cancer (NCT04112966) | University of Castilla-La Mancha | 2004-05-01 |
| Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors (NCT00872677) | Barbara Ann Karmanos Cancer Institute | 2004-05-01 |
| Pilot Bioequivalency Study of Exemestane 25 mg Tablet Under Fasted Conditions (NCT01331447) | Roxane Laboratories | 2004-05-01 |
| Chemoradiation for Bone Metastasis (NCT01784393) | Rabin Medical Center | 2004-05-01 |
| PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer (NCT00236275) | Assistance Publique - Hôpitaux de Paris | 2004-05-01 |
| Arimidex Bone Mass Index and Oral Bisphosphonates (NCT00809484) | Hellenic Breast Surgeons Society | 2004-05-01 |
| Three Doses of TAS-108 to Treat Recurrent or Recurrent Inoperable Breast Cancer (NCT00166543) | SRI International | 2004-05-01 |
| Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors (NCT00078845) | M.D. Anderson Cancer Center | 2004-05-01 |
| Breast Study Investigating a New Light Technique to Monitor Changes in Breast Tissue Density (NCT00188760) | University Health Network, Toronto | 2004-05-01 |
| DPPE in Combination With Epirubicin and Cyclophosphamide in the Treatment of Breast Cancer (NCT00099281) | YM BioSciences | 2004-05-01 |
| Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 (NCT00369850) | ETOP IBCSG Partners Foundation | 2004-05-01 |
| A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer (NCT00234403) | AstraZeneca | 2004-05-01 |
| Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer (NCT00087178) | NSABP Foundation Inc | 2004-05-01 |
| A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression (NCT00676793) | Louisiana State University Health Sciences Center Shreveport | 2004-05-01 |
| A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer (NCT00337649) | Hoffmann-La Roche | 2004-05-01 |
| Letrozole With or Without Zoledronate in Treating Healthy Postmenopausal Women With High Breast Density (NCT00114270) | University of Virginia | 2004-05-01 |
| Trastuzumab and Irinotecan in Treating Patients With HER2/Neu Positive Metastatic Breast Cancer (NCT00303992) | University of California, San Francisco | 2004-05-01 |
| Thoracoscopic Sentinel Lymph Node Biopsy in Patients With Stage I or Stage II Breast Cancer (NCT00450723) | University of Miami | 2004-05-01 |
| Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer (NCT00096057) | Jonsson Comprehensive Cancer Center | 2004-05-01 |
| Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer (NCT00084669) | Massachusetts General Hospital | 2004-05-01 |
| Radiation Therapy During Surgery in Treating Older Women With Stage I Breast Cancer (NCT00556777) | Institut du Cancer de Montpellier - Val d'Aurelle | 2004-04-19 |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery (NCT00665457) | University of Nebraska | 2004-04-15 |
| Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole (NCT00077168) | Institute of Cancer Research, United Kingdom | 2004-04-01 |
| Breast Ultrasound and Mammography in Screening Women at High Risk for Breast Cancer (NCT00072501) | American College of Radiology Imaging Network | 2004-04-01 |
| Radiation Therapy in Treating Women With Invasive Breast Cancer (NCT00301041) | University of California, San Francisco | 2004-04-01 |
| Hyperbaric Oxygen Therapy Compared With Standard Therapy in Treating Chronic Arm Lymphedema in Patients Who Have Undergone Radiation Therapy for Cancer (NCT00077090) | Institute of Cancer Research, United Kingdom | 2004-04-01 |
| Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy (NCT00165204) | Dana-Farber Cancer Institute | 2004-04-01 |
| Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer (NCT00259090) | AstraZeneca | 2004-04-01 |
| Physical Activity Promotion in Cancer Follow-Up Care (NCT00230711) | The Miriam Hospital | 2004-04-01 |
| Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer (NCT00082277) | AstraZeneca | 2004-04-01 |
| Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer (NCT00896857) | Wake Forest University Health Sciences | 2004-04-01 |
| Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer (NCT00256243) | Rita Sanghvi, Mehta | 2004-04-01 |
| S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer (NCT00075764) | SWOG Cancer Research Network | 2004-04-01 |
| Soy Isoflavones and Breast Cancer Risk Reduction (NCT00204490) | The University of Texas Medical Branch, Galveston | 2004-04-01 |